United States First Circuit

ResetAA Font size: Print

Kader v. Sarepta Therapeutics, Inc., 17-1139

Affirming the district court dismissal of a case in which a class of purchasers of securities issued by a drug company that the investors said recklessly misled them about their target date for submitting an application to the Food and Drug Administration for a drug approval because the court did not err in finding that they had failed to state a claim.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2018/04/04




  • United States First Circuit


FindLaw Career Center

    Select a Job Title

      Post a Job  |  Careers Home

    View More